Sun Pharmaceutical Industries receives four observations from USFDA for its Halol facility

22 Jun 2019 Evaluate

Sun Pharmaceutical Industries has received four observations from United States Food and Drug Administration (USFDA) for its Halol facility in Gujarat. The company will submit its response on the observations to the USFDA within 15 business days. The company is committed to addressing these observations promptly.

The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAl) of company's Halol facility from June 3 to June 11, 2019.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.